A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Clinical trial NCT07035093 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07035093
Sponsor: Eli Lilly and Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight Chronic Low Back Pain (CLBP)

Start date: 2025-05-29
Primary completion: 2027-09-01
Enrollment: 586

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.